Harishankar Natesan

Harishankar Natesan

Auto-generated profile, based on publicly available information

Harishankar Natesan

Boston Scientific Corporation Arden Hills MN 55112 USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Review of Scientific Instruments
Verified
Journal Article
Closed access
PDF file
SLSean D. Lubner
Sean D. Lubner
JCJeunghwan Choi
Jeunghwan Choi
GWGeoff Wehmeyer
Geoff Wehmeyer
BWBastian Waag
Bastian Waag
VMVivek Mishra
Vivek Mishra
CDChris Dames
Chris Dames
Accurate knowledge of the thermal conductivity (k) of biological tissues is important for cryopreservation, thermal ablation, and cryosurgery. Here, we adapt the 3ω method—widely used for rigid, inorganic solids—as a reusable sensor to measure k of soft biological samples two orders of magnitude thinner than conventional tissue characterization methods. Analytical and numerical studies quantify the error of the commonly used “boundary mismatch approximation” of the bi-directional 3ω geometry, confirm that the generalized slope method is exact in the low-frequency limit, and bound its error for finite frequencies. The bi-directional 3ω measurement device is validated using control experiments to within ±2% (liquid water, standard deviation) and ±5% (ice). Measurements of mouse liver cover a temperature ranging from −69 °C to +33 °C. The liver results are independent of sample thicknesses from 3 mm down to 100 μm and agree with available literature for non-mouse liver to within the measurement scatter.

1 June 2018 in Biomaterials
Verified
Journal Article
Closed access
FPFrancisco Pelaez
Francisco Pelaez
NMNavid Manuchehrabadi
Navid Manuchehrabadi
Priyatanu RoyPriyatanu Roy
Priyatanu Roy
HNHarishankar Natesan
Harishankar Natesan
YWYiru Wang
Yiru Wang
SASamira M. Azarin
Samira M. Azarin

24 January 2017 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
HNHarishankar Natesan
Harishankar Natesan
JBJohn Bischof
John Bischof

28 March 2022 in Advanced Therapeutics
Verified
Journal Article
Open access
PRPegah Ranjbartehrani
Pegah Ranjbartehrani
MEMichael Etheridge
Michael Etheridge
SRSatish Ramadhyani
Satish Ramadhyani
HNHarishankar Natesan
Harishankar Natesan
JBJohn Bischof
John Bischof
QSQi Shao
Qi Shao
Focal therapies, including cryosurgery, thermal ablation, and irreversible electroporation (IRE) are widely used in the treatment of cancer and other diseases, aimed at exposing cancer cells to extreme physical conditions leading to cell death. Focal ablation outcomes are extensively studied in small animal preclinical models, such as mice; however, robust engineering characterization of these treatments is largely lacking, due in a large part to the lack of control in applying clinical devices (cm scale) to mouse tumors (mm scale). To address this issue, miniaturized probes are designed and built for controlled application of cryosurgery, thermal ablation, and IRE and their performance is evaluated using ex vivo porcine liver tissue and an in vivo MC‐38 tumor model. These experimental results are compared to simulated conditions in heat transfer (cryosurgery and thermal ablation) and electrical (IRE) models. Agreements of physical quantities between measurement and modeling are shown for all the focal therapy cases. The in vivo outcome is further correlated with tumor growth delay. The characterization improves the understanding of the energy dose to create tissue damage, therefore enables to better understand outcomes in preclinical studies and predict and optimize the outcome of future clinical procedures.

8 September 2020 in Journal of Biomechanical Engineering
Verified
Journal Article
Closed access
PDF file
HNHarishankar Natesan
Harishankar Natesan
Limei TianLimei Tian
Limei Tian
John A. RogersJohn A. Rogers
John A. Rogers
JBJohn Bischof
John Bischof
Treatment of atrial fibrillation by cryoablation of the pulmonary vein (PV) suffers from an inability to assess probe contact, tissue thickness, and freeze completion through the wall. Unfortunately, clinical imaging cannot be used for this purpose as these techniques have resolutions similar in scale (∼1 to 2 mm) to PV thickness and therefore are unable to resolve changes within the PV during treatment. Here, a microthermal sensor based on the “3ω” technique which has been used for thin biological systems is proposed as a potential solution and tested for a cryoablation scenario. First, the sensor was modified from a linear format to a serpentine format for integration onto a flexible balloon. Next, using numerical analyses, the ability of the modified sensor on a flat substrate was studied to differentiate measurements in limiting cases of ice, water, and fat. These numerical results were then complemented by experimentation by micropatterning the serpentine sensor onto a flat substrate and onto a flexible balloon. In both formats (flat and balloon), the serpentine sensor was experimentally shown to: (1) identify tissue contact versus fluid, (2) distinguish tissue thickness in the 0.5 to 2 mm range, and (3) measure the initiation and completion of freezing as previously reported for a linear sensor. This study demonstrates proof of principle that a serpentine 3ω sensor on a balloon can monitor tissue contact, thickness, and phase change which is relevant to cryo and other focal thermal treatments of PV to treat atrial fibrillation.

28 December 2020 in Cryobiology
Verified
Journal Article
Closed access
PRPegah Ranjbartehrani
Pegah Ranjbartehrani
QSQi Shao
Qi Shao
HNHarishankar Natesan
Harishankar Natesan
SRSatish Ramadhyani
Satish Ramadhyani
JBJohn Bischof
John Bischof